ghk-cu fda approval status regulatory Topical: Evidence, Safety & Options Is GHK-Cu FDA-Approved? fda approval status of ghk-cu

5-Amino-1MQ Vials (10 mg each): 1 week (5 mg/day = 35 mg total) 4 vials 2 weeks (5 mg/day = 70 mg total) 7 vials 4 weeks (5 mg/day = 140 mg total) 14 vials Insulin Syringes (U-100, 1 mL): 1 week (once daily): 7 syringes 2 weeks (once daily): 14 syringes 4 weeks (once daily): 28 syringes Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution

Safety Profile: Preclinical data indicate a wide safety margin for BPC-157 (no lethal dose up to ~20 mg/kg)

PMID 29155147

Livers Enzymatic Processes: BAC reduction is primarily governed by the livers enzymatic processes, and hydration does not expedite this natural metabolic function